| Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders K Downes, K Megy, D Duarte, M Vries, J Gebhart, S Hofer, O Shamardina, ... Blood, The Journal of the American Society of Hematology 134 (23), 2082-2091, 2019 | 236 | 2019 |
| Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS) J Gebhart, F Posch, S Koder, T Perkmann, P Quehenberger, C Zoghlami, ... Blood, The Journal of the American Society of Hematology 125 (22), 3477-3483, 2015 | 85 | 2015 |
| High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: results from the Vienna Bleeding Biobank (VIBB) J Gebhart, S Hofer, S Panzer, P Quehenberger, R Sunder‐Plassmann, ... Haemophilia 24 (3), 405-413, 2018 | 79 | 2018 |
| Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause D Mehic, S Hofer, C Jungbauer, A Kaider, H Haslacher, E Eigenbauer, ... Blood advances 4 (20), 5157-5164, 2020 | 53 | 2020 |
| Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause S Hofer, C Ay, J Rejtö, AS Wolberg, H Haslacher, S Koder, I Pabinger, ... Journal of Thrombosis and Haemostasis 17 (9), 1478-1488, 2019 | 51 | 2019 |
| High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant J Gebhart, F Posch, S Koder, P Quehenberger, T Perkmann, L Kuessel, ... Blood advances 3 (5), 769-776, 2019 | 44 | 2019 |
| Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxaban O Königsbrügge, P Quehenberger, S Belik, G Weigel, C Seger, ... Annals of hematology 94 (9), 1463-1471, 2015 | 44 | 2015 |
| In utero exposure to Azathioprine in autoimmune disease. Where do we stand? C Belizna, PL Meroni, Y Shoenfeld, K Devreese, J Alijotas-Reig, ... Autoimmunity Reviews 19 (9), 102525, 2020 | 38 | 2020 |
| Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant F Posch, J Gebhart, JH Rand, S Koder, P Quehenberger, V Pengo, C Ay, ... BMC medicine 15 (1), 54, 2017 | 38 | 2017 |
| Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma J Gebhart, K Lechner, C Skrabs, T Sliwa, E Müldür, H Ludwig, ... Thrombosis Research 134 (5), 980-984, 2014 | 37 | 2014 |
| The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency J Gebhart, S Hofer, A Kaider, J Rejtö, C Ay, I Pabinger European Journal of Internal Medicine 78, 34-40, 2020 | 36 | 2020 |
| Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause J Gebhart, S Kepa, S Hofer, S Koder, A Kaider, AS Wolberg, H Haslacher, ... Annals of hematology 96 (3), 489-495, 2017 | 33 | 2017 |
| Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH RI Baker, P Choi, N Curry, J Gebhart, K Gomez, Y Henskens, ... Journal of thrombosis and haemostasis 22 (7), 2059-2070, 2024 | 31 | 2024 |
| Expert report on immune thrombocytopenia: current diagnostics and treatment–recommendations from an expert group from Austria, Germany, and Switzerland A Matzdorff, SR Alesci, J Gebhart, S Holzhauer, ML Hütter-Krönke, ... Oncology research and treatment 46 (Suppl. 2), 5-44, 2023 | 31 | 2023 |
| Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals LM Mauracher, M Krall, J Roiß, L Hell, S Koder, TM Hofbauer, J Gebhart, ... Rheumatology 60 (4), 1687-1699, 2021 | 30 | 2021 |
| Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency D Mehic, A Tolios, S Hofer, C Ay, H Haslacher, J Rejtö, WH Ouwehand, ... Blood advances 5 (2), 391-398, 2021 | 30 | 2021 |
| Altered platelet proteome in lupus anticoagulant (LA)-positive patients—Protein disulfide isomerase and NETosis as new players in LA-related thrombosis L Hell, K Lurger, LM Mauracher, E Grilz, CM Reumiller, GJ Schmidt, ... Experimental & molecular medicine 52 (1), 66-78, 2020 | 29 | 2020 |
| Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia D Mehic, J Machacek, T Schramm, L Buresch, A Kaider, B Eichelberger, ... Thrombosis Research 223, 102-110, 2023 | 26 | 2023 |
| Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank D Mehic, G Neubauer, F Janig, A Kaider, C Ay, I Pabinger, J Gebhart Journal of Thrombosis and Haemostasis 21 (7), 1757-1768, 2023 | 25 | 2023 |
| Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non‐severe haemophilia A J Rejtő, O Königsbrügge, E Grilz, S Hofer, LM Mauracher, C Gabler, ... Journal of Thrombosis and Haemostasis 18 (5), 1081-1086, 2020 | 24 | 2020 |
Pabinger Ingrid or Pabinger-Faching I...Medical University Vienna, Division of Haematology and HaemostaseologyVerified email at meduniwien.ac.at
